A Guide for Efficacious Data Integrity During COVID-19

Learn how ProPharma Group implements data integrity measures to prevent reputation damage, unsafe products, and costs.
With the current pandemic creating schedule delays, interrupting supply chains, and reducing margins, it’s more important than ever that companies are able to trust their data for better quality decision making.
This whitepaper provides guidance for ensuring data integrity through COVID-19 and after, including insights about:
  • How MHRA inspectors approach your employees and assess your company
  • Why company culture is such a critical – yet often overlooked – component of data integrity
  • Finding gaps in your data integrity plan using 4 key steps
  • Using the acronym “ALCOA” to provide a framework for additional questions
  • Preparing a proper data integrity approach using only 2 phases

Thanks for your submission

Download Whitepaper



The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...


Free Webinar: Effective FDA Engagement

FDA faces challenges (like new technology) and new review models (like real world evidence) that stretch agency standards and practices. At the same time, imperatives like product safety and efficacy...


Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma Group offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma Group’s Compliance and Quality team completed the...